報價延遲最少15分鐘:2025/08/25 12:32 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
265.59 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
3.78/4.99
|
|
企業價值
10.53B
|
| 資產負債 |
|
每股賬面淨值
33.18
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
1.19B
|
|
每股收益
25.51
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/08/25 12:32 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products. |
